期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Leptin对子宫颈癌Hela细胞生物学行为的影响及机制 被引量：3

Effects of Leptin on biological behavior of cervical cancer Hela cells and its mechanism
下载PDF
导出
摘要 目的观察瘦素(Leptin)对子宫颈癌Hela细胞生物学行为的影响,并探讨其机制。方法用不同浓度Leptin重组蛋白处理子宫颈癌Hela细胞,MTT法检测细胞增殖状态的变化;流式细胞仪检测瘤细胞周期变化及凋亡;RT-PCR检测C-MYC基因的表达;Western blot检测C-MYC蛋白质的表达。结果 Leptin明显促进子宫颈癌Hela细胞的增殖并抑制细胞的凋亡;Leptin激活子宫颈癌Hela细胞中C-MYC基因及其蛋白质的表达。结论 Leptin通过激活C-MYC的表达促进子宫颈癌Hela细胞的增殖并抑制其凋亡,其作用机制通过激活癌基因C-MYC而发挥效应。 Purpose To investigate the effect of Leptin on the biological behavior of Hela cells of cervical cancer and to elucidate its molecular mechanism.Methods Hela cells of cervical cancer were treated with different concentrations of Leptin protein.The cell proliferation was detected by MTT assay and the apoptosis was analyzed by flow cytometry.At the same times,real-time PCR and Western blot were used to detect the expression of C-MYC oncogene in Hela cells.Results Leptin increased significantly the growth of cervical cancer Hela cells in a dose-dependent and time-dependent manner.Flow cytometry revealed that Leptin inhibited the cell apoptosis.C-myc mRNA and protein expression in Hela cells were up-regulated significantly.Conclusions Leptin can significantly increase the growth of cervical cancer,and its mechanism might be related to the activation of the oncogene C-MYC.
作者 袁勇 王晓敏 陆建荣 张娟 丁彩霞 蔡琳 黄颖楠 王祥
机构地区 陕西省肿瘤医院病理科
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第2期162-165,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 陕西省科学技术研究发展计划(社发公关2010k14-03-11)
关键词 子宫颈肿瘤 LEPTIN C-MYC 细胞增殖 细胞凋亡 cervical neoplasms Leptin C-MYC proliferation apoptosis
分类号 R737.33 [医药卫生—肿瘤] R73-3 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1侯晓琳,何春年.磷脂酰肌醇-3-激酶/丝苏氨酸蛋白激酶(PI3K/Akt)信号转导通路与子宫颈癌关系的研究现状[J].临床与实验病理学杂志,2011,27(8):878-881. 被引量：9
  • 2Zhang Y,Proenca R,Maffei M,et al.Positional cloning of the mouse obese gene and its human homologue[J].Nature,1994,372(6505):425-32.
  • 3Villanueva E C,Myers M G Jr.Leptin receptor signaling and the regulation of mammalian physiology[J].Int J Obes (Lond),2008,32(7):8-12.
  • 4Dardeno T A,Chou S H,Moon H S,et al.Leptin in human physiology and therapeutics[J].Front Neuroendocrinol,2010,31(3):377-93.
  • 5Sheffield L.Malignant transformation of mammary epithelial cells increases expression of leptin and leptin receptor[J].Endocr Res,2008,33(3):111-8.
  • 6Ray A,Cleary M P.Leptin as a potential therapeutic target for breast cancer prevention and treatment[J].Expert Opin Ther Targets,2010,14(4):443-51.
  • 7Perera C N,Chin H G,Duru N.et al.Leptin-regulated gene expression in MCF-7 breast cancer cells:mechanistic insights into leptin-regulated mammary tumor growth and progression[J].J Endocrinol,2008,199(2):221-33.
  • 8Escobar-morreale H F.Sanmillan J L.Abdominal adiposity and the polycystic ovary syndrome.Trends in endocrinologyand metabolism[J].Trends End ocrinol Metab,2007,18(7):266-72.
  • 9Sharma D,Saxena N K,Vertino P M.et al.Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways[J].Endocr Relat Cancer,2006,13(2):629-40.
  • 10Jaffe T,Schwartz B.Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways[J].Int J Cancer,2008,123(11):2543-56.

二级参考文献30

  • 1夏曙,于世英.抑制PI3K/Akt提高药物对HeLa细胞放射增敏作用的研究[J].中华放射肿瘤学杂志,2006,15(5):419-422. 被引量：9
  • 2Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statis tics, 2002[J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 3Yuan T L, Cantley L C. PI3K pathway alterations in cancer: vail- ationsons on a theme [ J ]. Oncogene, 2008,27 (41) :5497 - 510.
  • 4Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer [ J ]. Apoptosis, 2004,9 (6) :667 - 76.
  • 5Edwards L A, Thiessen B, Dragowska W H, et al. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt acti- vation, induces apoptosis, and delays tumor growth [ J ]. Oncogene, 2005,24(22) :3596 -605.
  • 6Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival[ J]. J Cell Mol Med, 2005,9 (1) :59 - 71.
  • 7Sharrard R M, Maitland N J. Regulation of protein kinase B activ- ity by PTEN and SHIP2 in human prostate-derived cell lines [ J ]. Cell Signal, 2007,19 ( 1 ) : 129 - 38.
  • 8Gao T, Fumari F, Newton A C. PHLPP: a phosphatase that di- rectly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth[ J] Mol Cell, 2005,18 ( 1 ) : 13 - 24.
  • 9Zhang M, Fang X, Liu H, et al. Bioinformatics-based discovery and characterization of an Akt-selective inhibitor 9-chloro-2-meth- ylellipticinium acetate (CMEP) in breast cancer cells[J]. Cancer Lett, 2007,252 ( 2 ) :244 - 58.
  • 10Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation [ J]. J Biol Chem, 2005,280 (11) :10781 -9.

共引文献8

同被引文献23

  • 1Guignard R, Truong T, Rougier Y, et al. Alcohol drinking, to- bacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Cale- donia J1. Am J Epidemiol, 2007,166(10) :1140 -9.
  • 2Capezzone M, Morabito E, Bellitti P, et al. Increasing incidence of thyroid cancer in Basilicata: an Italian study [ J ]. J Endocrinol Invest, 2007,30(6) :507 - 12.
  • 3Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue[ J]. Nature, 1994, 372 (6505) : 425 -32.
  • 4Tessitore L, Vizio B, Pesola D, et al. Adipocyte expression and circulating levels of Leptin increase in both gynaecological and breast cancer patients [ J]. Int J Oncol, 2004,24 (6) : 1529 - 35.
  • 5Uddin S, Bu R, Ahmed M, et al. Overexpression of leptin recep- tor predicts an unfavorable outcome in Middle Eastern ovarian cancer[ J ]. Mol Cancer, 2009,8:74.
  • 6Cheng S P, Chi C W, Tzen C Y, et al. Clinicopathologic signifi- cance of Leptin and Leptin receptor expressions in papillary thyroid carcinoma[J]. Surgery, 2010,147(6) : 847 -53.
  • 7Uddin S, Bavi P, Siraj A K, et al. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma [ J]. Endocr Relat Cancer, 2010,17 ( 1 ) : 191 - 202.
  • 8Wincewicz A, Koda M, Sulkowska M, et al. Comparison of STAT3 with HIF-lalpha, Ob and ObR expressions in human endo- metrioid adenocarcinomas [ J . Tissue Cell, 2008,40 ( 6 ) : 405 - 10.
  • 9Koda M, Sulkowska M, Kanczuga-Koda L, et al. Expression of the obesity hormone Leptin and its receptor correlates with hypoxia- inducible factor-1 alpha in human colorectal cancer[ J]. Ann On- col, 2007,18 ( Suppl 6 ) : vi116 - 9.
  • 10Koda M, Kanczuga-Koda L, Sulkowska M, et al. Relationships between hypoxia markers and the Leptin system, estrogen receptors in human primary and metastatic breast cancer : effects of preoper- ative chemotherapy[ J]. BMC Cancer,2010,10:320.

引证文献3

二级引证文献4

临床与实验病理学杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部